Page last updated: 2024-08-23

raloxifene hydrochloride and acetylcysteine

raloxifene hydrochloride has been researched along with acetylcysteine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Baillie, TA; Blizzard, TA; Cai, X; Chen, Q; DiNinno, FP; Doss, GA; Evans, DC; Hammond, ML; Ngui, JS; Stearns, RA; Tang, W; Wang, RW1
Kaufmann, Y; Klimberg, VS; Luo, S; Todorova, VK1
Aurrekoetxea, I; del Agua, AR; Elorriaga, MA; Guéraud, F; Rodriguez, F; Ruiz-Larrea, MB; Ruiz-Sanz, JI1
Aguado, T; Botella, LM; Del Río, M; Ferrer-Mayorga, G; García, A; García, M; Martínez-Santamaría, L; Sánchez-Puelles, JM1

Other Studies

5 other study(ies) available for raloxifene hydrochloride and acetylcysteine

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Cytochrome P450 3A4-mediated bioactivation of raloxifene: irreversible enzyme inhibition and thiol adduct formation.
    Chemical research in toxicology, 2002, Volume: 15, Issue:7

    Topics: Acetylcysteine; Animals; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Female; Gas Chromatography-Mass Spectrometry; Glutathione; Hepatocytes; Humans; Magnetic Resonance Spectroscopy; Male; Microsomes, Liver; Oxidation-Reduction; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Sulfhydryl Compounds

2002
Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake.
    Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:2

    Topics: Acetylcysteine; Amino Acid Transport System ASC; Antioxidants; Apoptosis; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Estradiol; Female; Gene Expression; Glutamine; Glutathione; Humans; Minor Histocompatibility Antigens; Oxidative Stress; Raloxifene Hydrochloride; Receptors, Estrogen; Tamoxifen

2011
Involvement of G-463A MPO gene polymorphism in the response of postmenopausal women to hormone therapy.
    Menopause (New York, N.Y.), 2011, Volume: 18, Issue:5

    Topics: Acetylcysteine; alpha-Tocopherol; Antioxidants; Estradiol; Female; Hormone Replacement Therapy; Humans; Intercellular Adhesion Molecule-1; Lipids; Malondialdehyde; Middle Aged; Peroxidase; Polymorphism, Genetic; Postmenopause; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Uric Acid

2011
Raloxifene and n-Acetylcysteine Ameliorate TGF-Signalling in Fibroblasts from Patients with Recessive Dominant Epidermolysis Bullosa.
    Cells, 2020, 09-16, Volume: 9, Issue:9

    Topics: Acetylcysteine; Activin Receptors, Type II; Antioxidants; Case-Control Studies; Collagen Type VII; Drug Repositioning; Endoglin; Epidermolysis Bullosa; Estrogen Antagonists; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Gene Expression Regulation; Humans; Inheritance Patterns; Primary Cell Culture; Raloxifene Hydrochloride; Receptor, Transforming Growth Factor-beta Type I; Severity of Illness Index; Signal Transduction; Skin; Smad Proteins; Transforming Growth Factor beta1

2020